Faye, a pioneering name in the travel insurance sector, is thrilled to announce its successful funding round, securing an impressive $31 million to enhance and expand its innovative coverage solutions. Recognized as one of the Best Travel Insurance Companies of 2023 by The Wall Street Journal, and boasting accolades such as a 2023 LinkedIn Top 10 Startup On The Rise and the #12 Best Startup To Work for by Dun & Bradstreet, Faye is redefining how travelers protect their journeys. This round of funding will be utilized to further develop our cutting-edge technology, ensuring our app provides seamless, real-time solutions that cater to every traveler's needs鈥攆rom health and trip coverage to safeguarding personal belongings and even pets. Our commitment is not only to provide comprehensive travel insurance but to transform the industry by offering faster claims resolutions and 24/7 access to dedicated customer experience specialists who are ready to turn any travel mishap into a humorous anecdote for future adventures. With this financial backing, we are excited to continue to innovate and set new standards that challenge the norms of an industry often plagued by inefficiency. We invite all travel enthusiasts to join us on this journey, as we leverage technology and unparalleled service to create unforgettable travel experiences, allowing everyone to explore the world with confidence.
Faye Secures $31M in Series B Funding to Revolutionize the Travel Insurance Industry
Recently funded 路 $31.0M Series bTravel Insurance
Get the full Faye company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
